City (and Growth) Deals: the Why, When, Where and How / The Centre for Food at Drug Discovery Growth Deal for Coleraine: Building on Expertise for Future Success
City (and Growth) Deals: the Why, When, Where and How
A City (and Growth) Deal is a package of funding and decision-making powers agreed between central government, devolved government and local councils aimed at helping to harness additional investment, create new jobs and accelerate inclusive economic growth. There are currently 4 City (and Growth) Deals in Northern Ireland with a £1.3 billion package of capital investment funding for over 50 projects to be delivered over the next 10-15 years. Ulster University is a key partner in 3 of the 4 City (and Growth) Deals as Project Promoter for key aspects of the innovation strand which will enable Northern Ireland to better compete in the data-driven knowledge economy of the future through new open-source facilities for research and development. The projects are designed to embed a culture of innovation in the region and act as catalysts for increased productivity. The Faculty of Computing, Engineering & the Built Environment (CEBE) is leading on 2 major City Deal Innovation Projects, one each in the Belfast Region Council Deal (BRCD) and the Derry City and Strabane District Council City Deal (DCSCD), as well as being a partner with Queen's University Belfast in a third BRCD innovation project. This talk will provide details of the nature, scope and scale of the CEBE City Deal Projects and provide an up-to-date overview of their progress and expected timeline to completion. Key aspects of their impact on and benefits to Computing and AI will be highlighted.
-------------------------------------------------------------
The Centre for Food at Drug Discovery Growth Deal for Coleraine: Building on Expertise for Future Success
To be confirmed.
Date and Time
Location
Hosts
Registration
-
Add Event to Calendar
Loading virtual attendance info...
- Contact Event Host
-
m.garcia-constantino@ulster.ac.uk
- Co-sponsored by Ulster University
Speakers
Brian of Ulster University
City (and Growth) Deals: the Why, When, Where and How
A City (and Growth) Deal is a package of funding and decision-making powers agreed between central government, devolved government and local councils aimed at helping to harness additional investment, create new jobs and accelerate inclusive economic growth. There are currently 4 City (and Growth) Deals in Northern Ireland with a £1.3 billion package of capital investment funding for over 50 projects to be delivered over the next 10-15 years. Ulster University is a key partner in 3 of the 4 City (and Growth) Deals as Project Promoter for key aspects of the innovation strand which will enable Northern Ireland to better compete in the data-driven knowledge economy of the future through new open-source facilities for research and development. The projects are designed to embed a culture of innovation in the region and act as catalysts for increased productivity. The Faculty of Computing, Engineering & the Built Environment (CEBE) is leading on 2 major City Deal Innovation Projects, one each in the Belfast Region Council Deal (BRCD) and the Derry City and Strabane District Council City Deal (DCSCD), as well as being a partner with Queen's University Belfast in a third BRCD innovation project. This talk will provide details of the nature, scope and scale of the CEBE City Deal Projects and provide an up-to-date overview of their progress and expected timeline to completion. Key aspects of their impact on and benefits to Computing and AI will be highlighted.
Biography:
Brian is Professor of Biomedical Materials and Associate Dean for Research & Impact, Faculty of Computing, Engineering, and the Built Environment, Ulster University. Brian's research interests are directed toward the development of enhanced biomaterials for medical device applications with particular emphasis on the promoting interactions on the sub-micron to nanometre scale for applications in tissue engineering and regenerative medicine. Core research projects include bioactive calcium phosphate thin-film coatings on bioresorbable magnesium alloys for bone fracture repair; modification of polymer surfaces by atmospheric dielectric barrier discharge (DBD) for medication of cell-surface interactions and the development of novel bioresponsive materials for 3D bioplotting. Brian has published over 165 peer-reviewed papers in leading journals and presented his work at many prestigious international conferences. He has secured grant income of more than £25M from various funders (UKRI, EU, Invest Northern Ireland, US-Ireland Fund) and has supervised over 30 PhD students to completion. Brian is also active in health technology evaluation and its role in medical device design and service delivery. His research has led to several patented inventions, and was Co-Founder, Director and Chairman of Surf-Spec Ltd., an Ulster University spin-out company established in 2013 to commercialise IP in atmospheric pressure plasma processing technology. Brian is currently the Senior Responsible Owner (SRO) for major Ulster University led City Deal Projects for the establishment of dedicated industry facing innovation centres in Digital Healthcare Technologies, Cognitive Analytics & AI and Industrial Robotics.
Email:
Julie-Anne of Ulster University
The Centre for Food at Drug Discovery Growth Deal for Coleraine: Building on Expertise for Future Success
To be confirmed.
Biography:
Prof. Julie-Anne Little (PhD BSc(Hons) MCOptom PgCERT FHEA Prof Cert Low Vision) is a Professor of Optometry and Vision Science at Ulster University, and is a UK optometrist with over 20 years experience. Her PhD and post-doctoral studies centred on the assessment and identification of visual loss in Down syndrome and learning disabilities. She is the Research Director for Biomedical Sciences, comprising >100 researchers spanning nutrition, diabetes, genomic medicine, pharmaceutical and vision science. The launch of the £20M Centre for Food and Drug Discovery will harness existing expertise to stimulate industry-academic research. Prof Little's research focuses on investigating refractive error, accommodation and visual function in childhood, and aims to optimise vision, educational attainment and quality of life through effective eye care and interventions for individuals across the world, and she has raised over £5.4M in research grant funding. To date, she has authored 52 peer-reviewed journal articles with >1000 citations, with publications predominantly in Q1 Scimago ranked journals in Ophthalmology and included in both UK REF2014 and REF2021 submissions for her University. She serves on the REF2029 People, Culture and Environment panel. Her research outputs demonstrate her sustained focus on improving vision and eyecare for people with developmental disability, using cutting-edge methodologies coupled with clinical expertise in conducting optometric assessment of hard-to-test groups. They also reflect her research investigating the impact of uncorrected hyperopia in children for reading and near tasks, and epidemiological work on unmet visual need. She contributes to postgraduate and undergraduate Optometry programmes and has a strong external profile in optometry as past President of the European Council of Optometry and Optics, and as Chairman of the Association of Optometrists in the UK.
Email: